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INTRODUCTION
The Stille cross-coupling reaction is a versatile method for the formation of carbon-carbon bonds and the construction of molecules containing sp 2 -sp 2 linkages. i Since its introduction by Migata ii and its subsequent exploration by Stille, iii it has evolved into one of the most robust forms of palladium-catalyzed cross-coupling reactions and has found applications in drug discovery, iv natural products synthesis, v and materials chemistry. vi The toxicity of organostannanes, vii and the difficulty in the removal of the tin byproducts have lead to an increase in the popularity of other C-C cross-coupling methods, specifically the SuzukiMiyaura reaction, viii but for difficult cases and late stage synthetic transformations the Stille reaction is still widely employed due to its reliable nature.
A great deal of effort in the field of Pd-catalyzed cross-coupling has been devoted to the development of catalysts that allow for less reactive and more stable aryl halides or pseudo halides to be employed in these reactions. Early methods utilized activated electrophilic coupling partners, such as aryl iodides, electron-deficient aryl bromides, and in the case of the Stille reaction, acid chlorides. 3 The advent of more active catalysts, based on electronrich phosphine ligands, has allowed for reactions of unactivated aryl bromides, aryl chlorides, and aryl sulfonates to be carried out efficiently. ix Aryl triflates were initially the most successfully employed aryl sulfonates for cross-coupling reactions. x However, due to the fact that aryl tosylates and mesylates are less expensive and more stable than the corresponding aryl triflates recent research has focused on utilizing these substrates in many cross-coupling reactions. xi Specifically, aryl tosylates have been shown to be effective coupling partners in Suzuki-Miyaura, Kumada-Corriu, and C-N cross-coupling reactions; xii aryl mesylates have been efficiently employed in Hiyama, Suzuki-Miyaura, and C-N crosscoupling reactions, as well as the Pd-catalyzed carbonylation reaction. xiii Further, vinyl tosylates have also been utilized in Stille cross-coupling reactions; xiv however, to date no examples of the Stille cross-coupling reactions of aryl tosylates and mesylates have been reported. Herein, we report a catalyst, based on 1 (XPhos), for the Pd-catalyzed Stille crosscoupling reactions of aryl mesylates and tosylates.
RESULTS AND DISCUSSION
We began our initial studies by investigating the reaction of 3-methoxyphenyl methanesulfonate and tributyl(phenyl)stannane. Attempts to use reaction conditions previously reported by our group for the Stille reaction of aryl chlorides, xv employing Pd(OAc) 2 and 1 in either 1,4-dioxane or DME as solvent provided very low yields (Table 1 , entries 1 and 2). An examination of non-ethereal solvents showed that a polar aprotic solvent, DMF, gave no desired product; while alcoholic solvents proved to be the best, with t-BuOH giving the highest yield (Table 1 , entries 3-5).
We next explored other biarylphosphine ligands and Pd sources in this reaction. Catalysts based on 2 (BrettPhos), which has been shown to form an efficient catalyst for the C-N cross-coupling of aryl mesylates, and 3 (SPhos) provided yields of 60% and 52% respectively (table 1, entries 6 and 7). Using a catalyst comprised of Pd(OAc) 2 and 4 (RuPhos) increased the yield of the reaction to 76% (Table 1, entry 8); however, 1 formed the most efficient catalyst system and furnished the desired product in 93% yield (Table 1 , entry 3). While other Pd sources, such as allylpalladium chloride dimer and 5, a single component precatalyst developed in our group, xvi gave similar results to palladium acetate for this reaction, we chose to continue our studies with palladium acetate because of its low cost and stability (Table 1 , entries 8 and 9). Pd 2 dba 3 was also examined, and only produced a 22% yield of the desired product (Table 1, entry 10). Finally, we wanted to explore the effect of increased ligand loading on the efficiency of the reaction. Entries 12-14 show these results. While the yields of the three quantities of ligand examined were similar, we found that a 1:2 ratio of Pd to ligand was optimal (Table 1, entries 11-13).
With these conditions in hand, we wanted to explore the scope of the Stille cross-coupling reaction of aryl sulfonates using Pd(OAc) 2 and XPhos. The results are summarized in Table  2 . We found that a variety of aryl and heteroaryl mesylates and tosylates could be coupled in moderate to good yields with aryl stannanes. These results represent the first reported Stille couplings of aryl tosylates and mesylates. Unactivated aryl mesylates and tosylates were coupled in good yields (Table 2 , entries 1-4). Slightly activated aryl mesylates, such as 3-methoxyphenyl mesylate and 4-fluorophenyl mesylate were also suitable coupling partners (Table 2 , entries 5-6). Heteroaryl containing mesylates (Table 2 , entries 7-8), which have been difficult substrates in other cross-coupling reactions, and a heteroaryl tosylate (Table 2 , entry 9) were successfully combined with aryl stannanes in good to moderate yields.
For example, using a catalyst comprised Pd(OAc) 2 and XPhos the reaction of 2-methylquinolin-6-yl methanesulfonate and tributyl(furan-2-yl)stannane provided the desired product in 78% yield. Finally, reactions were carried out with aryl sulfonates containing functional groups. Electron-withdrawing groups such as nitriles and trifluoromethyl groups were tolerated in this reaction (Table 2, entries 10-11), as well as an acetamide that contained a free N-H (Table 2, 
entry 12).
A range of tributylarylstannanes were also explored and found to work well in these coupling reactions. The simplest arylstannane, tributyl(phenyl)stannane, was combined with weakly activated mesylates (Table 2, entry 5), functional group containing mesylates (Table 2 , entries 11-12) and heteroaryl tosylates (Table 2, entry 9) with high efficiency. Arylstannanes containing ortho substitution, such as tributyl(2,6-dimethoxyphenyl)stannane (Table 2 , entry 1), tributyl(2-(trifluoromethyl)phenyl)stannane (Table 2, entries 3-4) , and tributyl(mesityl)-stannane (Table 2, entry 6) were effectively reacted with unactivated mesylates and tosylates. Additionally, heteroarylstannanes such as 2-furyl-, 2-thiophenyl-, and 2-(N-methylpyrrolyl)tributylstannane were shown to be proficient substrates in these reactions. (Table 2 , entries 2, 7, 8 and 10).
While we have revealed that this method tolerates a range of substrates, we also discovered some limitations in the scope. As described above, steric hindrance was well tolerated on the arylstannane, as shown by the reactions of tin reagents containing an o-CF 3 group, two oOMe groups, and even two o-Me groups. However, attempts to incorporate steric bulk in the ortho position of the aryl sulfonate resulted in greatly reduced reaction rates. xvii In addition to this limitation, there were certain classes of heterocycles that were not tolerated under these reaction conditions. While 3-pyridyltosylate was successfully coupled, the analogous mesylate, along with 2-pyridylmesylate provided no product; in both cases the hydroxypyridine was the only product observed. Similarly, several heteroarylstannanes provided no coupling product and lead to decomposition of the mesylate coupling partners to their parent phenols. These stannanes included the 2-thiazole, 2-oxazole, 2-pyrazinyl and 2-pyridyl derivatives.
In conclusion, a catalyst system comprised of XPhos and Pd(OAc) 2 used with CsF in tBuOH was developed for the Stille cross-coupling of aryl mesylates and aryl tosylates with aryl-and heteroarylstannanes. A total of 11 examples were reported including unactivated aryl mesylates and aryl tosylates, functional group containing aryl mesylates and both heteroaryl mesylates and hetero aryltosylates. The biaryl products were obtained in yields that ranged from 51-86%, and represent the first biaryl compounds made by Stille crosscoupling of aryl sulfonates.
EXPERIMENTAL General Reagent Information
All reactions were carried out under an argon atmosphere. The tert-butanol, 1,4-dioxane, DME, and DMF were purchased from Aldrich Chemical Company in Sure-Seal bottles and were used as received. Toluene was purchased from J.T. Baker in CYCLE-TAINER ® solvent-delivery kegs and vigorously purged with argon for 2 h. The solvent was further purified by passing it under argon pressure through two packed columns of neutral alumina and copper (II) oxide. Aryl mesylates, tosylates, and benzenesulfonates were synthesized using literature procedures. Aryl tin reagents were purchased from Aldrich Chemical Company, Alfa Aesar, and Gelest and were used as received. 2, 14 4, xviii and 5 17 were synthesized using literature procedures. Ligands 1 xix and 3 xx were purchased from Strem Chemicals and the CsF, Pd 2 (dba) 2 , PdCl 2 (CH 3 CN) 2 , and [(allyl)PdCl] 2 were purchased from Aldrich Chemical Company. Pd(OAc) 2 was received as a gift from BASF. Flash chromatography was performed using a Biotage SP4 instrument with prepacked silica cartridges.
General Analytical Information
All compounds were characterized by 1 H NMR, 13 C NMR, and IR spectroscopy. Copies of the 1 H and 13 C spectra can be found in the Supporting Information. Nuclear Magnetic Resonance spectra were recorded on a Varian 300 MHz instrument or a Bruker 400 MHz instrument. All 1 H NMR experiments are reported in δ units, parts per million (ppm), and were measured relative to the signals for residual chloroform (7.26 ppm) in the deuterated solvent, unless otherwise stated. All 13 C NMR spectra are reported in ppm relative to deuterochloroform (77.23 ppm), unless otherwise stated, and all were obtained with 1 H decoupling. All IR spectra were taken on a Perkin -Elmer 2000 FTIR. All GC analyses were performed on a Agilent 6890 gas chromatograph with an FID detector using a J & W DB-1 column (10 m, 0.1 mm I.D.). Table 1 An oven-dried test tube, which was equipped with a magnetic stir bar and fitted with a Teflon screw-cap septum, was charged with the Pd source (2 mol%), ligand (4 mol%), and CsF (1.1 mmol). The vessel was evacuated and backfilled with argon (this process was repeated a total of 3 times) and then the 3-methoxyphenyl methanesulfonate (101 mg, 0.5 mmol), tributyl(phenyl)stannane (221 mg, 0.6 mmol), and t-BuOH (1 mL) were added via syringe. The solution was heated to 110 °C for 14 h and then the reaction mixture was cooled to room temperature and filtered through a plug of silica (eluting with EtOAc). Biphenyl was then added as an internal standard and the reaction was analyzed by GC. Table 2 An oven-dried test tube, which was equipped with a magnetic stir bar and fitted with a Teflon screw-cap septum, was charged with the Pd(OAc) 2 (2 mol%), 1 (4 mol%), and CsF (2.2 mmol). The vessel was evacuated and backfilled with argon (this process was repeated a total of 3 times) and then the aryl sulfonate (1.0 mmol), stannane (1.2 mmol), and t-BuOH (2 mL) were added via syringe (aryl mesylates, tosylates, or benzenesulfonates that were solids at room temperature were added with the catalyst and base). The solution was heated to 110 °C for 44 h and then the reaction mixture was cooled to room temperature, filtered through a plug of silica (eluting with EtOAc), concentrated in vacuo, and purified via the Biotage SP4 (silica-packed 50 or 100 g snap cartridge). Table 2, 157.9, 149.3, 131.0, 130.6, 128.6, 124.8, 119.5 ppm. IR (neat, cm −1 ): 2961 157.9, 149.3, 131.0, 130.6, 128.6, 124.8, 119.5 ppm. IR (neat, cm −1 ): , 1587 157.9, 149.3, 131.0, 130.6, 128.6, 124.8, 119.5 ppm. IR (neat, cm −1 ): , 1471 157.9, 149.3, 131.0, 130.6, 128.6, 124.8, 119.5 ppm. IR (neat, cm −1 ): , 1430 157.9, 149.3, 131.0, 130.6, 128.6, 124.8, 119.5 ppm. IR (neat, cm −1 ): , 1384 157.9, 149.3, 131.0, 130.6, 128.6, 124.8, 119.5 ppm. IR (neat, cm −1 ): , 1245 157.9, 149.3, 131.0, 130.6, 128.6, 124.8, 119.5 ppm. IR (neat, cm −1 ): , 1109 . Table 2, 140.9, 139.6, 134.4, 132.5, 129.1, 129.0, 127.5, 127.3, 127.2, 124.1, 109.0, 108.1, 35.4 ppm. IR (neat, cm −1 ): 2953 140.9, 139.6, 134.4, 132.5, 129.1, 129.0, 127.5, 127.3, 127.2, 124.1, 109.0, 108.1, 35.4 ppm. IR (neat, cm −1 ): , 1478 140.9, 139.6, 134.4, 132.5, 129.1, 129.0, 127.5, 127.3, 127.2, 124.1, 109.0, 108.1, 35.4 ppm. IR (neat, cm −1 ): , 1446 140.9, 139.6, 134.4, 132.5, 129.1, 129.0, 127.5, 127.3, 127.2, 124.1, 109.0, 108.1, 35.4 ppm. IR (neat, cm −1 ): , 1408 140.9, 139.6, 134.4, 132.5, 129.1, 129.0, 127.5, 127.3, 127.2, 124.1, 109.0, 108.1, 35.4 ppm. IR (neat, cm −1 ): , 1309 140.9, 139.6, 134.4, 132.5, 129.1, 129.0, 127.5, 127.3, 127.2, 124.1, 109.0, 108.1, 35.4 ppm. IR (neat, cm −1 ): , 1061 . Trifluoromethyl)phenyl)-1,2,3,4-tetrahydronaphthalene (Table 2, entry 3) -Following the general procedure, a mixture of 5,6,7,8-tetrahydronaphthalen-2-yl methanesulfonate (237 mg, 1.0 mmol), tributyl(2-(trifluoromethyl)phenyl)stannane (522 mg, 1.2 mmol), Pd(OAc) 2 (4.4 mg, 2.0 mol%), 1 (19 mg, 4 mol%), CsF (334 mg, 2.2 mmol) , and t-BuOH (2 mL) was heated to 110 °C for 14 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-10% EtOAc/hexanes) to provide the title compound as a yellow oil (152 mg, 55%). 1 H NMR (300 MHz, CDCl 3 ) δ: 7.78 (d, J = 7.8 Hz, 1H), 7.58 (t, J = 7.5 Hz, 1H), 7.47 (t, J = 7.5 Hz, 1H), 7.38 (d, J = 6.9 Hz, 1H), 7.14 (m, 2H), 7.09 (s, 1H), 2.86 (m, 4H), 1.89 (m, 4H) ppm. 13 C NMR (75 MHz, CDCl 3 ) δ: 141.9, 141.8, 137.2, 136.7, 136.7, 132.4, 131.4, 131.4, 129.8, 129.8, 129.8, 129.8, 129.3, 128,8, 128.6, 128.4, 127.2, 126.3, 126.2, 126.1, 126.1, 125.6, 122.6, 29.6, 29.4, 23.6, 23.4 ppm. IR (neat, cm −1 ): 2931 , 1604 , 1486 , 1449 , 1315 , 1168 , 1127 , 1036 4′-tert-Butyl-2-(trifluoromethyl)biphenyl xxii (Table 2, entry 4)-Following the general procedure, a mixture of 4-tert-butylphenyl 4-methylbenzenesulfonate (304 mg, 1.0 mmol), tributyl(2-(trifluoromethyl)-phenyl)stannane (522 mg, 1.2 mmol), Pd(OAc) 2 (2.0 mol%) and 1 (4 mol%) as a pre-milled mixture (23.6 mg), CsF (334 mg, 2.2 mmol), and tBuOH (2 mL) was heated to 110 °C for 14 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; hexanes) to provide the title compound as a colorless oil (170 mg, 61%). 1 H NMR (400 MHz, CDCl 3 ) δ: 7.75 (d, J = 7.5 Hz, 1H), 7.54 (t, J =7.5 Hz, 1H), 7.44 (m, 3H), 7.34 (d, J = 7.5 Hz, 1H), 7.28 (d, J = 7.5 Hz, 2H), 1.38 (s, 9H) ppm. 13 C NMR (100 MHz, CDCl 3 ) δ: 150.7, 141.7, 141.7, 137.1, 132.4, 131.5, 129.1, 128.8, 128.8, 128.5, 128.2, 127.3, 126.3, 126.3, 126.2, 126.2, 125.8, 124.9, 123.1, 34.8, 31.6 ppm. IR (neat, cm −1 ): 2965 150.7, 141.7, 141.7, 137.1, 132.4, 131.5, 129.1, 128.8, 128.8, 128.5, 128.2, 127.3, 126.3, 126.3, 126.2, 126.2, 125.8, 124.9, 123.1, 34.8, 31.6 ppm. IR (neat, cm −1 ): , 2869 150.7, 141.7, 141.7, 137.1, 132.4, 131.5, 129.1, 128.8, 128.8, 128.5, 128.2, 127.3, 126.3, 126.3, 126.2, 126.2, 125.8, 124.9, 123.1, 34.8, 31.6 ppm. IR (neat, cm −1 ): , 1606 150.7, 141.7, 141.7, 137.1, 132.4, 131.5, 129.1, 128.8, 128.8, 128.5, 128.2, 127.3, 126.3, 126.3, 126.2, 126.2, 125.8, 124.9, 123.1, 34.8, 31.6 ppm. IR (neat, cm −1 ): , 1488 150.7, 141.7, 141.7, 137.1, 132.4, 131.5, 129.1, 128.8, 128.8, 128.5, 128.2, 127.3, 126.3, 126.3, 126.2, 126.2, 125.8, 124.9, 123.1, 34.8, 31.6 ppm. IR (neat, cm −1 ): , 1315 150.7, 141.7, 141.7, 137.1, 132.4, 131.5, 129.1, 128.8, 128.8, 128.5, 128.2, 127.3, 126.3, 126.3, 126.2, 126.2, 125.8, 124.9, 123.1, 34.8, 31.6 ppm. IR (neat, cm −1 ): , 1171 150.7, 141.7, 141.7, 137.1, 132.4, 131.5, 129.1, 128.8, 128.8, 128.5, 128.2, 127.3, 126.3, 126.3, 126.2, 126.2, 125.8, 124.9, 123.1, 34.8, 31.6 ppm. IR (neat, cm −1 ): , 1131 150.7, 141.7, 141.7, 137.1, 132.4, 131.5, 129.1, 128.8, 128.8, 128.5, 128.2, 127.3, 126.3, 126.3, 126.2, 126.2, 125.8, 124.9, 123.1, 34.8, 31.6 ppm. IR (neat, cm −1 ): , 1069 150.7, 141.7, 141.7, 137.1, 132.4, 131.5, 129.1, 128.8, 128.8, 128.5, 128.2, 127.3, 126.3, 126.3, 126.2, 126.2, 125.8, 124.9, 123.1, 34.8, 31.6 ppm. IR (neat, cm −1 ): , 1036 . 1, 143.0, 141.3, 130.0, 128.9, 127.6, 127.4, 119.9, 113.1, 112.8, 55.5 ppm. IR (neat, cm −1 ): 2937 1, 143.0, 141.3, 130.0, 128.9, 127.6, 127.4, 119.9, 113.1, 112.8, 55.5 ppm. IR (neat, cm −1 ): , 1599 1, 143.0, 141.3, 130.0, 128.9, 127.6, 127.4, 119.9, 113.1, 112.8, 55.5 ppm. IR (neat, cm −1 ): , 1573 1, 143.0, 141.3, 130.0, 128.9, 127.6, 127.4, 119.9, 113.1, 112.8, 55.5 ppm. IR (neat, cm −1 ): , 1479 1, 143.0, 141.3, 130.0, 128.9, 127.6, 127.4, 119.9, 113.1, 112.8, 55.5 ppm. IR (neat, cm −1 ): , 1421 1, 143.0, 141.3, 130.0, 128.9, 127.6, 127.4, 119.9, 113.1, 112.8, 55.5 ppm. IR (neat, cm −1 ): , 1296 1, 143.0, 141.3, 130.0, 128.9, 127.6, 127.4, 119.9, 113.1, 112.8, 55.5 ppm. IR (neat, cm −1 ): , 1213 1, 143.0, 141.3, 130.0, 128.9, 127.6, 127.4, 119.9, 113.1, 112.8, 55.5 ppm. IR (neat, cm −1 ): , 1020 4′-Fluoro-2,4,6-trimethylbiphenyl xxiv (Table 2, entry 6)-Following the general procedure, a mixture of 4-fluorophenyl methanesulfonate (190 mg, 1.0 mmol), tributyl(mesityl)-stannane (491 mg, 1.2 mmol), Pd(OAc) 2 (4.4 mg, 2.0 mol%), 1 (19 mg, 4 mol%), CsF (334 mg, 2.2 mmol), and t-BuOH (2 mL) was heated to 110 °C for 14 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-5% EtOAc/hexanes) to provide the title compound as a white solid (116 mg, 54%), mp = 65 -67 °C (literature 64 -65 °C). 1 H NMR (300 MHz, CDCl 3 ) δ: 7.14 (s, 2H), 7.11 (s, 2H), 6.97 (s, 2H) ppm. 13 C NMR (75 MHz, CDCl 3 ) δ: 163.5, 160. 3, 138.2, 137.0, 137.0, 136.4, 131.1, 130.9, 128.3, 115.7, 115.4, 109.9, 21.2, 21 .0 ppm. IR (neat, cm −1 ): 2921, 1601, 1511, 1478, 1217, 1151, 1087, 1008, 854, 815. 6-(Furan-2-yl)-2-methylquinoline (Table 2, entry 7)-Following the general procedure, a mixture of 2-methylquinolin-6-yl methanesulfonate (237 mg, 1.0 mmol), tributyl(furan-2-yl)stannane (430 mg, 1.2 mmol), Pd(OAc) 2 (4.4 mg, 2.0 mol%), 1 (19 mg, 4 mol%), CsF (334 mg, 2.2 mmol), and t-BuOH (2 mL) was heated to 110 °C for 14 h. The crude product was purified via the Biotage SP4 (silica-packed 50 g snap column; 0-40% EtOAc/hexanes) to provide the title compound as a white solid (175 mg, 84%), mp = 57 -59 °C. 1 Table 1 Palladium-catalyzed Stille couplings of 3-methanesulfonylanisole 
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